News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

Thanks to funding from NCI’s Small Business Innovation Research program, a new tool recently received FDA clearance. See how this cyber device could help you with artificial intelligence (AI)-guided glioblastoma segmentation.

An international team of researchers combined genomics, biopsy results, and artificial intelligence (AI) to track prostate cancer over time. Learn more about these “evolvability” metrics and how they could someday help predict cancer re-occurrence.

NCI-funded researchers are blending mathematics with machine learning to refine cancer treatment. In the future, this kind of virtual tumor model could help to further personalize care for people with cancer.

NCI researchers are using artificial intelligence (AI) to uncover additional information from medical images. This helps them not only to diagnose cancer but also to predict how it will progress and if it will re-occur.

A new, scalable, machine learning model is helping scientists model thousands of transcription factors and genes in the human genome, providing new information on these genes and how they work/change over time.

Learn how supercomputing and cancer research expertise helped transform a previously complex, ‘undruggable’ target into a promising, first-in-class medication. Researchers are now testing it in human trials.

In the study, artificial intelligence (AI)-assisted contours outperformed manual contours, indicating the technology’s potential to enhance treatment strategies and improve outcomes for patients.

Are you developing machine learning and looking for ways to make your model generalizable to a diverse population? A recent study describes an algorithm that centers on transforming your data rather than tweaking your model.

Discover a new AI-driven tool that uses single-cell RNA data to help predict patient responses to cancer treatments.

Learn about NCI’s LORIS, a new artificial intelligence-approach to help you predict how a patient will respond to immunotherapy.